D-0577-2020 Class II Terminated
FDA drug recall D-0577-2020 was initiated by Pfizer Inc. on Nov 27, 2019 and is designated Class II. Reason for recall: Labeling: Incorrect or Missing Lot and/or expiration date. The recall status is terminated (terminated Jan 14, 2022). Affected quantity: 77,100 syringes.
Recall details
- Product Type
- Drugs
- Report Date
- Dec 18, 2019
- Initiation Date
- Nov 27, 2019
- Termination Date
- Jan 14, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 77,100 syringes
Product description
25% Dextrose Injection, USP 2.5 grams (250 mg/mL) 10 mL Single-dose, Rx Only, Hospira, Inc., Lake Forest, IL 60045 USA, NDC 0409-1775-10
Reason for recall
Labeling: Incorrect or Missing Lot and/or expiration date.
Distribution pattern
Nationwide within the United States including Puerto Rico.
Code information
Lot #: 80-292-EV, 1AUG2019 on carton. Expiration date printed on syringe is 1AUG2021 which is incorrect.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0577-2020
- openFDA file date
- Nov 19, 2026
- Loaded by RegDataLab
- Nov 20, 2026
Need the full FDA record for Pfizer Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.